GLI1 activation is a key mechanism of erlotinib resistance in human non‑small cell lung cancer-Reference-Cited by-同舟云学术

GLI1 activation is a key mechanism of erlotinib resistance in human non‑small cell lung cancer

Published:2020-07-31 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Dong Zhouhuan¹,Wang Yun¹,Ding Vivianne²,Yan Xiang³,Lv Yali¹,Zhong Mei¹,Zhu Fengwei¹,Zhao Po¹,He Charlotte²,Ding Feng⁴,Shi Huaiyin¹

Affiliation:

1. Department of Pathology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China

2. Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94115, USA

3. Department of Medical Oncology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China

4. Zhejiang Provincial Key Laboratory of Applied Enzymology and Precision Medicine Center, Jiaxing, Zhejiang 314006, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02

2. N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness;Cell Death Discovery;2023-05-06

3. Signaling Switching from Hedgehog-GLI to MAPK Signaling Potentially Serves as a Compensatory Mechanism in Melanoma Cell Lines Resistant to GANT-61;Biomedicines;2023-05-03

4. AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma;International Journal of General Medicine;2022-08

5. Xprediction: Explainable EGFR-TKIs response prediction based on drug sensitivity specific gene networks;PLOS ONE;2022-05-18